Impedimed Common Stock Total Equity vs Retained Earnings Analysis

IPD Stock

0.04 0 2.50%

Impedimed financial indicator trend analysis is infinitely more than just investigating Impedimed recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Impedimed is a good investment. Please check the relationship between Impedimed Common Stock Total Equity and its Retained Earnings accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Common Stock Total Equity vs Retained Earnings

Common Stock Total Equity vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Impedimed Common Stock Total Equity account and Retained Earnings. At this time, the significance of the direction appears to have pay attention.

The correlation between Impedimed's Common Stock Total Equity and Retained Earnings is -0.86. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Impedimed, assuming nothing else is changed. The correlation between historical values of Impedimed's Common Stock Total Equity and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Impedimed are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Common Stock Total Equity i.e., Impedimed's Common Stock Total Equity and Retained Earnings go up and down completely randomly.

Correlation Coefficient

-0.86

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most indicators from Impedimed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Impedimed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Tax Provision is likely to gain to about 40.3 K in 2025, whereas Selling General Administrative is likely to drop slightly above 13.6 M in 2025.

	2022	2023	2024	2025 (projected)
Cost Of Revenue	25.0M	1.3M	1.5M	1.4M
Total Revenue	11.3M	10.3M	11.9M	12.5M

Cost Of Revenue Total Revenue

Impedimed fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Other Liab	Accounts Payable	Other Assets	Long Term Debt	Net Receivables	Good Will	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding
Total Assets		0.01	0.2	0.34	0.59	0.31	-0.42	0.46	0.61	0.06	0.62	0.29	0.31	0.59	0.37	0.17	0.98	0.36	-0.9	-0.5	0.92	0.33	-0.06	0.92	0.68	0.38
Other Current Liab	0.01		0.94	0.08	0.26	0.24	0.61	0.36	0.19	-0.54	0.33	0.89	0.19	0.03	0.03	-0.18	0.1	0.06	-0.06	-0.12	0.07	0.14	-0.02	0.07	0.13	0.12
Total Current Liabilities	0.2	0.94		0.14	0.52	0.41	0.46	0.56	0.36	-0.56	0.51	0.96	0.32	0.22	0.13	-0.27	0.25	0.15	-0.2	-0.32	0.21	0.24	-0.19	0.21	0.35	0.23
Other Liab	0.34	0.08	0.14		0.01	0.67	-0.13	0.66	0.66	-0.53	0.12	0.35	0.94	0.84	0.91	0.39	0.29	0.91	0.01	-0.77	0.08	0.98	0.44	0.08	0.46	0.97
Accounts Payable	0.59	0.26	0.52	0.01		0.52	-0.26	0.44	0.53	0.07	0.78	0.47	0.17	0.45	0.02	-0.33	0.53	0.01	-0.52	-0.48	0.52	0.14	-0.3	0.52	0.64	0.18
Other Assets	0.31	0.24	0.41	0.67	0.52		-0.31	0.75	0.84	-0.42	0.63	0.53	0.77	0.87	0.67	0.08	0.18	0.66	0.04	-0.93	0.01	0.76	0.08	0.01	0.77	0.76
Long Term Debt	-0.42	0.61	0.46	-0.13	-0.26	-0.31		-0.24	-0.39	-0.31	-0.34	0.37	-0.06	-0.44	-0.17	-0.13	-0.23	-0.14	0.18	0.45	-0.18	-0.1	0.14	-0.18	-0.6	-0.17
Net Receivables	0.46	0.36	0.56	0.66	0.44	0.75	-0.24		0.74	-0.66	0.49	0.71	0.8	0.76	0.67	0.0	0.37	0.67	-0.13	-0.86	0.17	0.72	-0.13	0.17	0.79	0.77
Good Will	0.61	0.19	0.36	0.66	0.53	0.84	-0.39	0.74		-0.36	0.63	0.52	0.72	0.87	0.66	0.3	0.52	0.65	-0.27	-0.87	0.33	0.74	0.15	0.33	0.89	0.73
Inventory	0.06	-0.54	-0.56	-0.53	0.07	-0.42	-0.31	-0.66	-0.36		-0.09	-0.66	-0.66	-0.37	-0.53	0.02	0.05	-0.55	-0.24	0.47	0.2	-0.58	-0.09	0.2	-0.27	-0.57
Other Current Assets	0.62	0.33	0.51	0.12	0.78	0.63	-0.34	0.49	0.63	-0.09		0.52	0.21	0.54	0.26	0.03	0.53	0.25	-0.49	-0.59	0.49	0.21	-0.24	0.49	0.8	0.21
Total Liab	0.29	0.89	0.96	0.35	0.47	0.53	0.37	0.71	0.52	-0.66	0.52		0.51	0.38	0.35	-0.08	0.32	0.36	-0.19	-0.48	0.21	0.43	-0.13	0.21	0.48	0.42
Intangible Assets	0.31	0.19	0.32	0.94	0.17	0.77	-0.06	0.8	0.72	-0.66	0.21	0.51		0.85	0.89	0.23	0.25	0.89	0.05	-0.84	0.04	0.98	0.26	0.04	0.54	0.97
Common Stock	0.59	0.03	0.22	0.84	0.45	0.87	-0.44	0.76	0.87	-0.37	0.54	0.38	0.85		0.82	0.2	0.48	0.81	-0.23	-0.94	0.3	0.88	0.24	0.3	0.79	0.9
Property Plant Equipment	0.37	0.03	0.13	0.91	0.02	0.67	-0.17	0.67	0.66	-0.53	0.26	0.35	0.89	0.82		0.51	0.31	1.0	-0.03	-0.77	0.11	0.9	0.28	0.11	0.52	0.87
Short Long Term Debt Total	0.17	-0.18	-0.27	0.39	-0.33	0.08	-0.13	0.0	0.3	0.02	0.03	-0.08	0.23	0.2	0.51		0.18	0.52	-0.02	-0.15	0.06	0.31	0.28	0.06	0.15	0.2
Total Stockholder Equity	0.98	0.1	0.25	0.29	0.53	0.18	-0.23	0.37	0.52	0.05	0.53	0.32	0.25	0.48	0.31	0.18		0.31	-0.94	-0.36	0.97	0.27	-0.03	0.97	0.55	0.31
Property Plant And Equipment Net	0.36	0.06	0.15	0.91	0.01	0.66	-0.14	0.67	0.65	-0.55	0.25	0.36	0.89	0.81	1.0	0.52	0.31		-0.03	-0.76	0.11	0.91	0.28	0.11	0.51	0.87
Net Debt	-0.9	-0.06	-0.2	0.01	-0.52	0.04	0.18	-0.13	-0.27	-0.24	-0.49	-0.19	0.05	-0.23	-0.03	-0.02	-0.94	-0.03		0.11	-0.99	0.03	0.16	-0.99	-0.37	-0.02
Retained Earnings	-0.5	-0.12	-0.32	-0.77	-0.48	-0.93	0.45	-0.86	-0.87	0.47	-0.59	-0.48	-0.84	-0.94	-0.77	-0.15	-0.36	-0.76	0.11		-0.17	-0.83	-0.08	-0.17	-0.86	-0.85
Cash	0.92	0.07	0.21	0.08	0.52	0.01	-0.18	0.17	0.33	0.2	0.49	0.21	0.04	0.3	0.11	0.06	0.97	0.11	-0.99	-0.17		0.06	-0.09	1.0	0.4	0.11
Non Current Assets Total	0.33	0.14	0.24	0.98	0.14	0.76	-0.1	0.72	0.74	-0.58	0.21	0.43	0.98	0.88	0.9	0.31	0.27	0.91	0.03	-0.83	0.06		0.39	0.06	0.53	0.98
Non Currrent Assets Other	-0.06	-0.02	-0.19	0.44	-0.3	0.08	0.14	-0.13	0.15	-0.09	-0.24	-0.13	0.26	0.24	0.28	0.28	-0.03	0.28	0.16	-0.08	-0.09	0.39		-0.09	-0.09	0.37
Cash And Short Term Investments	0.92	0.07	0.21	0.08	0.52	0.01	-0.18	0.17	0.33	0.2	0.49	0.21	0.04	0.3	0.11	0.06	0.97	0.11	-0.99	-0.17	1.0	0.06	-0.09		0.4	0.11
Common Stock Total Equity	0.68	0.13	0.35	0.46	0.64	0.77	-0.6	0.79	0.89	-0.27	0.8	0.48	0.54	0.79	0.52	0.15	0.55	0.51	-0.37	-0.86	0.4	0.53	-0.09	0.4		0.56
Common Stock Shares Outstanding	0.38	0.12	0.23	0.97	0.18	0.76	-0.17	0.77	0.73	-0.57	0.21	0.42	0.97	0.9	0.87	0.2	0.31	0.87	-0.02	-0.85	0.11	0.98	0.37	0.11	0.56

Click cells to compare fundamentals

Impedimed Account Relationship Matchups

Impedimed fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	34.2M	58.7M	68.7M	47.0M	54.0M	37.4M
Other Current Liab	5.6M	3.5M	3.2M	3.2M	3.7M	3.0M
Total Current Liabilities	8.1M	7.2M	5.8M	4.7M	5.4M	4.8M
Other Liab	87K	398K	413K	864K	993.6K	1.0M
Accounts Payable	1.3M	2.6M	1.4M	1.1M	1.3M	1.4M
Net Receivables	2.8M	2.7M	2.6M	2.2M	2.5M	1.4M
Good Will	2.4M	2.6M	2.7M	2.7M	3.1M	2.5M
Inventory	372K	926K	810K	759K	683.1K	912.9K
Other Current Assets	2.8M	2.3M	2.8M	1.9M	2.2M	1.7M
Total Liab	8.7M	7.7M	7.9M	6.2M	7.2M	5.2M
Intangible Assets	7.5M	11.4M	14.8M	13.3M	15.3M	16.1M
Common Stock	267.3M	307.6M	336.1M	336.1M	386.6M	405.9M
Property Plant Equipment	1.0M	418K	2.0M	1.4M	1.7M	1.7M
Short Long Term Debt Total	474K	170K	1.4M	1.1M	1.3M	799.6K
Total Stockholder Equity	25.5M	51.0M	60.9M	40.7M	46.9M	34.4M
Property Plant And Equipment Net	1.0M	418K	2.0M	1.4M	1.7M	1.7M
Net Debt	(19.2M)	(40.6M)	(44.3M)	(23.5M)	(21.1M)	(22.2M)
Retained Earnings	(270.8M)	(290.6M)	(311.2M)	(331.0M)	(297.9M)	(283.0M)
Cash	19.7M	40.7M	45.7M	24.6M	28.3M	28.3M
Non Current Assets Total	8.6M	12.0M	16.8M	17.5M	20.2M	21.2M
Non Currrent Assets Other	(8.6M)	(11.9M)	(16.8M)	13.3M	12.0M	12.6M
Cash And Short Term Investments	19.7M	40.7M	45.7M	24.6M	28.3M	28.3M
Common Stock Shares Outstanding	1.2B	1.7B	1.8B	2.0B	2.3B	2.4B
Liabilities And Stockholders Equity	34.2M	58.7M	68.7M	47.0M	54.0M	39.2M
Non Current Liabilities Total	557K	413K	2.0M	1.6M	1.8M	1.9M
Property Plant And Equipment Gross	3.4M	3.8M	5.6M	5.7M	6.5M	6.8M
Total Current Assets	25.7M	46.7M	51.9M	29.5M	33.9M	32.8M
Accumulated Other Comprehensive Income	29.0M	34.1M	36.0M	35.5M	40.9M	42.9M
Short Term Debt	(562K)	(758K)	141K	333K	299.7K	314.7K
Net Tangible Assets	20.8M	18.1M	39.7M	46.1M	41.5M	28.0M
Current Deferred Revenue	877K	928K	1.0M	1.5M	1.7M	1.8M
Long Term Investments	73K	75K	78K	54K	48.6K	62.5K
Net Invested Capital	25.5M	51.0M	60.9M	40.7M	46.9M	43.5M
Cash And Equivalents	11.5M	31.3M	13.5M	18.4M	16.5M	16.7M
Net Working Capital	17.5M	39.4M	46.1M	24.8M	22.3M	24.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC